JMP Securities Raises Vanda Pharmaceuticals Inc. (VNDA) Price Target to $22.00
The brokerage currently has a "market outperform" rating on the biopharmaceutical company's stock. JMP Securities' price objective indicates a potential upside of 55.26% from the company's current price.
from Biotech News
0 Comments